Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242706 (
hyperoxia
)
5,219
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Basic fibroblast growth factor (bFGF) is a mitogenic polypeptide for a wide variety of cell types and has been immunolocalized in the rodent and human lung. We investigated the mRNA and protein expression of bFGF in hyperoxic-injured adult mouse lungs using northern blot analysis and immunohistochemistry. Mice (6-8 weeks) were continuously exposed to 80% oxygen up to 4 days. Levels of bFGF mRNA were increased from room air control on days 3 and 4 of
hyperoxia
. mRNA levels of acidic fibroblast growth factor (aFGF), fibronectin, and
transin
/
stromelysin
were also examined in this injury model. Similar to bFGF, the fibronectin and
transin
/
stromelysin
mRNA levels were increased after 3 days of
hyperoxia
. In contrast, the aFGF mRNA levels were gradually reduced on each day of
hyperoxia
. A rabbit polyclonal anti-bFGF antibody was used to determine the distribution and levels of expression in the hyperoxic-injured lungs. The room air control and day 1 hyperoxic-exposed lungs exhibited staining for bFGF in the basement membranes of the blood vessels, airways, and alveoli. Patchy but intense alveolar staining was prominent on day 4 of
hyperoxia
. The bFGF immunoreactivity of blood vessels and airways was unaffected by the
hyperoxia
exposure. These results suggest that bFGF may play a role in the alveolar response to hyperoxic-induced injury by virtue of the altered mRNA levels and protein distribution in this injury model.
...
PMID:Increased expression of basic fibroblast growth factor in hyperoxic-injured mouse lung. 753 14